{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:05:12Z","timestamp":1791929112884,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000101"],"award-info":[{"award-number":["2016YFC1000101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2022-1-2111"],"award-info":[{"award-number":["2022-1-2111"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z181100001718076"],"award-info":[{"award-number":["Z181100001718076"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subclinical hypothyroidism (SCH) is linked to dyslipidaemia and adverse pregnancy outcomes. However, the impact of dyslipidaemia on the outcome of pregnancy in SCH is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 36,256 pregnant women and evaluated their pregnancy outcomes. The following data was gathered during the first trimester (\u2264\u200913<jats:sup>+\u20096<\/jats:sup> weeks of gestation): total cholesterol (TC), low-density lipoprotein (LDL-C), triglyceride (TG), high-density lipoprotein (HDL-C), free thyroxine (FT4) and thyroid-stimulating hormone (TSH) concentrations. The reference ranges for lipids were estimated to range from the 5th to the 95th percentile. Logistic regression assessed the relationships between dyslipidaemia and adverse pregnancy outcomes, including abortion, preeclampsia\/eclampsia, low birth weight, foetal growth restriction, premature rupture of foetal membranes, gestational hypertension, preterm birth, macrosomia and gestational diabetes mellitus (GDM). Additionally, the best thresholds for predicting adverse pregnancy outcomes based on TSH, FT4, and lipid levels were determined using receiver operating characteristic curves.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the first trimester, LDL-C\u2009&gt;\u20093.24 mmol\/L, TG\u2009&gt;\u20091.92 mmol\/L, HDL-C\u2009&lt;\u20091.06 mmol\/L, and TC\u2009&gt;\u20095.39 mmol\/L were used to define dyslipidaemia. In this cohort, 952 (3.56%) patients were diagnosed with SCH, and those who had dyslipidaemia in the first trimester had higher incidences of gestational hypertension (6.59% vs. 3.25%), preeclampsia\/eclampsia (7.14% vs. 3.12%), GDM (22.53% vs. 13.77%), and low birth weight (4.95% vs. 2.08%) than did those without dyslipidaemia. However, after adjusting for prepregnancy body mass index (pre-BMI), dyslipidaemia was no longer related to these risks. Furthermore, elevated TG dyslipidaemia in SCH patients was connected to an enhanced potential of gestational hypertension (odds ratio [OR]: 2.687, 95% confidence interval [CI]: 1.074\u2009~\u20096.722), and elevated LDL-C dyslipidaemia correlated with increased preeclampsia\/eclampsia risk (OR: 3.172, 95% CI: 1.204\u2009~\u20098.355) after accounting for age, smoking status, alcohol use, pre-BMI, and levothyroxine use. Additionally, the combination of TC, TG, LDL-C, pre-BMI, and TSH exhibited enhanced predictive capabilities for gestational hypertension, preeclampsia\/eclampsia, and GDM. Values of 0.767, 0.704, and 0.706 were obtained from the area under the curve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among pregnant women with SCH, dyslipidaemia in early pregnancy was related to elevated risks of adverse pregnancy consequences. The combined consideration of age, pre-BMI, TSH, and lipid levels in the first trimester could be beneficial for monitoring patients and implementing interventions to reduce adverse pregnancy outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01998-7","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:02:56Z","timestamp":1704970976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Xueran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"issue":"3","key":"1998_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1042\/cs20090640","volume":"119","author":"E Jarvie","year":"2010","unstructured":"Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond). 2010;119(3):123\u20139. https:\/\/doi.org\/10.1042\/cs20090640.","journal-title":"Clin Sci (Lond)"},{"key":"1998_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2018.05.051","volume":"276","author":"NC Serrano","year":"2018","unstructured":"Serrano NC, Guio-Mahecha E, Quintero-Lesmes DC, Becerra-Bayona S, Paez MC, Beltran M, et al. Lipid profile, plasma apolipoproteins, and pre-eclampsia risk in the GenPE case-control study. Atherosclerosis. 2018;276:189\u201394. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.051.","journal-title":"Atherosclerosis"},{"issue":"6","key":"1998_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11892-018-1008-2","volume":"18","author":"LA Barbour","year":"2018","unstructured":"Barbour LA, Hernandez TL. Maternal non-glycemic contributors to fetal growth in obesity and gestational Diabetes: spotlight on lipids. Curr Diab Rep. 2018;18(6):37. https:\/\/doi.org\/10.1007\/s11892-018-1008-2.","journal-title":"Curr Diab Rep"},{"issue":"9","key":"1998_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/obr.12693","volume":"19","author":"J Wang","year":"2018","unstructured":"Wang J, Moore D, Subramanian A, Cheng KK, Toulis KA, Qiu X, et al. Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta-analysis. Obes Rev. 2018;19(9):1256\u201368. https:\/\/doi.org\/10.1111\/obr.12693.","journal-title":"Obes Rev"},{"issue":"1","key":"1998_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ecl.2015.09.004","volume":"45","author":"R Wild","year":"2016","unstructured":"Wild R, Weedin EA, Wilson D. Dyslipidemia in pregnancy. Endocrinol Metab Clin North Am. 2016;45(1):55\u201363. https:\/\/doi.org\/10.1016\/j.ecl.2015.09.004.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9186","key":"1998_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/s0140-6736(99)02131-5","volume":"354","author":"C Napoli","year":"1999","unstructured":"Napoli C, Glass CK, Witztum JL, Deutsch R, D\u2019Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet. 1999;354(9186):1234\u201341. https:\/\/doi.org\/10.1016\/s0140-6736(99)02131-5.","journal-title":"Lancet"},{"issue":"7","key":"1998_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11883-022-01030-w","volume":"24","author":"J Lewek","year":"2022","unstructured":"Lewek J, Banach M. Dyslipidemia Management in pregnancy: why is it not covered in the guidelines? Curr Atheroscler Rep. 2022;24(7):547\u201356. https:\/\/doi.org\/10.1007\/s11883-022-01030-w.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"1998_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s2213-8587(13)70109-8","volume":"1","author":"W Teng","year":"2013","unstructured":"Teng W, Shan Z, Patil-Sisodia K, Cooper DS. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):228\u201337. https:\/\/doi.org\/10.1016\/s2213-8587(13)70109-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1998_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12916-021-02130-1","volume":"19","author":"NA van Vliet","year":"2021","unstructured":"van Vliet NA, Bos MM, Thesing CS, Chaker L, Pietzner M, Houtman E, et al. Higher thyrotropin leads to unfavorable lipid profile and somewhat higher Cardiovascular Disease risk: evidence from multi-cohort mendelian randomization and metabolomic profiling. BMC Med. 2021;19(1):266. https:\/\/doi.org\/10.1186\/s12916-021-02130-1.","journal-title":"BMC Med"},{"issue":"6","key":"1998_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s2213-8587(20)30061-9","volume":"8","author":"A Derakhshan","year":"2020","unstructured":"Derakhshan A, Peeters RP, Taylor PN, Bliddal S, Carty DM, Meems M, et al. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2020;8(6):501\u201310. https:\/\/doi.org\/10.1016\/s2213-8587(20)30061-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1998_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s2213-8587(22)00007-9","volume":"10","author":"FJK Toloza","year":"2022","unstructured":"Toloza FJK, Derakhshan A, M\u00e4nnist\u00f6 T, Bliddal S, Popova PV, Carty DM, et al. Association between maternal thyroid function and risk of gestational Hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2022;10(4):243\u201352. https:\/\/doi.org\/10.1016\/s2213-8587(22)00007-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"1998_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jama.2019.10931","volume":"322","author":"TIM Korevaar","year":"2019","unstructured":"Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with Preterm Birth: a systematic review and Meta-analysis. JAMA. 2019;322(7):632\u201341. https:\/\/doi.org\/10.1001\/jama.2019.10931.","journal-title":"JAMA"},{"issue":"1","key":"1998_CR13","doi-asserted-by":"publisher","first-page":"19689","DOI":"10.1038\/s41598-021-99252-6","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Xu Y, Sun Z, Cai Y, Wang B, Zhang M, et al. Differential lipids in pregnant women with subclinical hypothyroidism and their correlation to the pregnancy outcomes. Sci Rep. 2021;11(1):19689. https:\/\/doi.org\/10.1038\/s41598-021-99252-6.","journal-title":"Sci Rep"},{"key":"1998_CR14","doi-asserted-by":"publisher","first-page":"792536","DOI":"10.3389\/fendo.2021.792536","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai Y, Xu Y, Ban Y, Li J, Sun Z, Zhang M, et al. Plasma lipid Profile and intestinal microflora in pregnancy women with hypothyroidism and their correlation with pregnancy outcomes. Front Endocrinol (Lausanne). 2021;12:792536. https:\/\/doi.org\/10.3389\/fendo.2021.792536.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1998_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10654-021-00831-8","volume":"37","author":"W Yue","year":"2022","unstructured":"Yue W, Zhang E, Liu R, Zhang Y, Wang C, Gao S, et al. The China birth cohort study (CBCS). Eur J Epidemiol. 2022;37(3):295\u2013304. https:\/\/doi.org\/10.1007\/s10654-021-00831-8.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"1998_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the American thyroid Association for the diagnosis and management of thyroid Disease during pregnancy and the Postpartum. Thyroid. 2017;27(3):315\u201389. https:\/\/doi.org\/10.1089\/thy.2016.0457.","journal-title":"Thyroid"},{"issue":"2","key":"1998_CR17","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/aog.0000000000004251","volume":"137","author":"Fetal Growth Restriction","year":"2021","unstructured":"Fetal Growth Restriction. ACOG Practice Bulletin, Number 227. Obstet Gynecol. 2021;137(2):e16\u2013e28. https:\/\/doi.org\/10.1097\/aog.0000000000004251.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1998_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0028-2243(92)90190-a","volume":"45","author":"W Piechota","year":"1992","unstructured":"Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;45(1):27\u201335. https:\/\/doi.org\/10.1016\/0028-2243(92)90190-a.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1998_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2018.06.884","volume":"276","author":"D Busso","year":"2018","unstructured":"Busso D, Rigotti A. Blood lipids during pregnancy: a progressively appreciated subject in basic and clinical research. Atherosclerosis. 2018;276:163\u20135. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.884.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1998_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00467-003-1082-8","volume":"18","author":"SM De Assis","year":"2003","unstructured":"De Assis SM, Seguro AC, Helou CM. Effects of maternal hypercholesterolemia on pregnancy and development of offspring. Pediatr Nephrol. 2003;18(4):328\u201334. https:\/\/doi.org\/10.1007\/s00467-003-1082-8.","journal-title":"Pediatr Nephrol"},{"key":"1998_CR21","doi-asserted-by":"publisher","first-page":"951871","DOI":"10.3389\/fendo.2022.951871","volume":"13","author":"SM Zhu","year":"2022","unstructured":"Zhu SM, Zhang HQ, Li C, Zhang C, Yu JL, Wu YT, et al. Maternal lipid profile during early pregnancy and birth weight: a retrospective study. Front Endocrinol (Lausanne). 2022;13:951871. https:\/\/doi.org\/10.3389\/fendo.2022.951871.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1998_CR22","doi-asserted-by":"publisher","unstructured":"Jiang XF, Wang H, Wu DD, Zhang JL, Gao L, Chen L, et al. The impact of Gestational Weight Gain on the risks of adverse maternal and infant outcomes among normal BMI women with high triglyceride levels during early pregnancy. Nutrients. 2021;13(10). https:\/\/doi.org\/10.3390\/nu13103454.","DOI":"10.3390\/nu13103454"},{"issue":"2","key":"1998_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jp.2016.191","volume":"37","author":"C Wang","year":"2017","unstructured":"Wang C, Zhu W, Wei Y, Su R, Feng H, Hadar E, et al. The associations between early pregnancy lipid profiles and pregnancy outcomes. J Perinatol. 2017;37(2):127\u201333. https:\/\/doi.org\/10.1038\/jp.2016.191.","journal-title":"J Perinatol"},{"issue":"6","key":"1998_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1600-0412.2012.01391.x","volume":"91","author":"LM Mudd","year":"2012","unstructured":"Mudd LM, Holzman CB, Catov JM, Senagore PK, Evans RW. Maternal lipids at mid-pregnancy and the risk of preterm delivery. Acta Obstet Gynecol Scand. 2012;91(6):726\u201335. https:\/\/doi.org\/10.1111\/j.1600-0412.2012.01391.x.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"1998_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12944-021-01565-y","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Wang X, Jiang F, Chen W, Li J, Chen X. Serum lipid levels in relation to clinical outcomes in pregnant women with gestational Diabetes Mellitus: an observational cohort study. Lipids Health Dis. 2021;20(1):125. https:\/\/doi.org\/10.1186\/s12944-021-01565-y.","journal-title":"Lipids Health Dis"},{"key":"1998_CR26","doi-asserted-by":"publisher","unstructured":"Ellerbrock J, Hubers E, Ghossein-Doha C, Schiffer V, Alers RJ, Jorissen L, et al. Second-trimester constituents of the metabolic syndrome and pregnancy outcome: an Observational Cohort Study. Nutrients. 2022;14(14). https:\/\/doi.org\/10.3390\/nu14142933.","DOI":"10.3390\/nu14142933"},{"issue":"2","key":"1998_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Cooper DS, Subclinical Hypothyroidism. Rev Jama. 2019;322(2):153\u201360. https:\/\/doi.org\/10.1001\/jama.2019.9052.","journal-title":"Rev Jama"},{"key":"1998_CR28","doi-asserted-by":"publisher","unstructured":"Liu H, Peng D. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. Endocr Connect. 2022;11(2). https:\/\/doi.org\/10.1530\/ec-21-0002.","DOI":"10.1530\/ec-21-0002"},{"issue":"5","key":"1998_CR29","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1194\/jlr.M047654","volume":"56","author":"X Zhang","year":"2015","unstructured":"Zhang X, Song Y, Feng M, Zhou X, Lu Y, Gao L, et al. Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver. J Lipid Res. 2015;56(5):963\u201371. https:\/\/doi.org\/10.1194\/jlr.M047654.","journal-title":"J Lipid Res"},{"key":"1998_CR30","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/srep07633","volume":"5","author":"S Ma","year":"2015","unstructured":"Ma S, Jing F, Xu C, Zhou L, Song Y, Yu C, et al. Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3. Sci Rep. 2015;5:7633. https:\/\/doi.org\/10.1038\/srep07633.","journal-title":"Sci Rep"},{"key":"1998_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2017.07.006","volume":"76","author":"Y Gong","year":"2017","unstructured":"Gong Y, Ma Y, Ye Z, Fu Z, Yang P, Gao B, et al. Thyroid stimulating hormone exhibits the impact on LDLR\/LDL-c via up-regulating hepatic PCSK9 expression. Metabolism. 2017;76:32\u201341. https:\/\/doi.org\/10.1016\/j.metabol.2017.07.006.","journal-title":"Metabolism"},{"key":"1998_CR32","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.12659\/msm.891163","volume":"20","author":"XL Liu","year":"2014","unstructured":"Liu XL, He S, Zhang SF, Wang J, Sun XF, Gong CM, et al. Alteration of lipid profile in subclinical hypothyroidism: a meta-analysis. Med Sci Monit. 2014;20:1432\u201341. https:\/\/doi.org\/10.12659\/msm.891163.","journal-title":"Med Sci Monit"},{"issue":"12","key":"1998_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","volume":"18","author":"J Hurtubise","year":"2016","unstructured":"Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF. The different facets of Dyslipidemia and Hypertension in Atherosclerosis. Curr Atheroscler Rep. 2016;18(12):82. https:\/\/doi.org\/10.1007\/s11883-016-0632-z.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"1998_CR34","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/hypertensionaha.111.179440","volume":"58","author":"FP McCarthy","year":"2011","unstructured":"McCarthy FP, Drewlo S, English FA, Kingdom J, Johns EJ, Kenny LC, et al. Evidence implicating peroxisome proliferator-activated receptor-\u03b3 in the pathogenesis of preeclampsia. Hypertension. 2011;58(5):882\u20137. https:\/\/doi.org\/10.1161\/hypertensionaha.111.179440.","journal-title":"Hypertension"},{"issue":"1","key":"1998_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jjcc.2012.08.017","volume":"61","author":"X Chen","year":"2013","unstructured":"Chen X, Zhang N, Cai Y, Shi J. Evaluation of left ventricular diastolic function using tissue Doppler echocardiography and conventional doppler echocardiography in patients with subclinical hypothyroidism aged\u2009<\u200960 years: a meta-analysis. J Cardiol. 2013;61(1):8\u201315. https:\/\/doi.org\/10.1016\/j.jjcc.2012.08.017.","journal-title":"J Cardiol"},{"issue":"6","key":"1998_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/thy.2007.0051","volume":"17","author":"PJ Owen","year":"2007","unstructured":"Owen PJ, Sabit R, Lazarus JH. Thyroid Disease and vascular function. Thyroid. 2007;17(6):519\u201324. https:\/\/doi.org\/10.1089\/thy.2007.0051.","journal-title":"Thyroid"},{"issue":"25 Suppl 2","key":"1998_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice guidelines. Circulation. 2014;129(25 Suppl 2):1\u201345. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a.","journal-title":"Circulation"},{"issue":"1","key":"1998_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12884-022-04950-2","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yuan H, Wang X, Zhang Z, Liu R, Yin C. Significance of levothyroxine treatment on serum lipid in pregnant women with subclinical hypothyroidism. BMC Pregnancy Childbirth. 2022;22(1):623. https:\/\/doi.org\/10.1186\/s12884-022-04950-2.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1998_CR39","doi-asserted-by":"publisher","first-page":"591588","DOI":"10.3389\/fendo.2020.591588","volume":"11","author":"LY Sue","year":"2020","unstructured":"Sue LY, Leung AM. Levothyroxine for the treatment of subclinical hypothyroidism and Cardiovascular Disease. Front Endocrinol (Lausanne). 2020;11:591588. https:\/\/doi.org\/10.3389\/fendo.2020.591588.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1998_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/er.2018-00163","volume":"40","author":"B Biondi","year":"2019","unstructured":"Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and Diabetes Mellitus: two closely Associated disorders. Endocr Rev. 2019;40(3):789\u2013824. https:\/\/doi.org\/10.1210\/er.2018-00163.","journal-title":"Endocr Rev"},{"issue":"2","key":"1998_CR41","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1210\/clinem\/dgab637","volume":"107","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun F, Wu P, Huang Y, Ye Y, Yang X, et al. A prospective study of early-pregnancy thyroid markers, lipid species, and risk of gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2022;107(2):e804\u2013e14. https:\/\/doi.org\/10.1210\/clinem\/dgab637.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1998_CR42","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/ajcn\/nqab242","volume":"114","author":"Y Wang","year":"2021","unstructured":"Wang Y, Huang Y, Wu P, Ye Y, Sun F, Yang X, et al. Plasma lipidomics in early pregnancy and risk of gestational Diabetes Mellitus: a prospective nested case-control study in Chinese women. Am J Clin Nutr. 2021;114(5):1763\u201373. https:\/\/doi.org\/10.1093\/ajcn\/nqab242.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1998_CR43","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1038\/s41598-021-87135-9","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wan K, Gong Y, Zhang X, Liang Y, Wang X, et al. Assessing the relationship between pregravid body mass index and risk of adverse maternal pregnancy and neonatal outcomes: prospective data in Southwest China. Sci Rep. 2021;11(1):7591. https:\/\/doi.org\/10.1038\/s41598-021-87135-9.","journal-title":"Sci Rep"},{"issue":"1","key":"1998_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.diabet.2015.06.001","volume":"42","author":"E Cosson","year":"2016","unstructured":"Cosson E, Cussac-Pillegand C, Benbara A, Pharisien I, Nguyen MT, Chiheb S, et al. Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational Diabetes Mellitus: a retrospective observational study. Diabetes Metab. 2016;42(1):38\u201346. https:\/\/doi.org\/10.1016\/j.diabet.2015.06.001.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1998_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/1471-0528.13293","volume":"123","author":"DR Farias","year":"2016","unstructured":"Farias DR, Franco-Sena AB, Vilela A, Lepsch J, Mendes RH, Kac G. Lipid changes throughout pregnancy according to pre-pregnancy BMI: results from a prospective cohort. BJOG. 2016;123(4):570\u20138. https:\/\/doi.org\/10.1111\/1471-0528.13293.","journal-title":"BJOG"},{"issue":"4","key":"1998_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/1471-0528.13296","volume":"123","author":"P Catalano","year":"2016","unstructured":"Catalano P. Maternal pre-pregnancy BMI: harbinger of late-pregnancy maternal lipid profile. BJOG. 2016;123(4):579. https:\/\/doi.org\/10.1111\/1471-0528.13296.","journal-title":"BJOG"},{"issue":"7","key":"1998_CR47","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1210\/jc.2004-2225","volume":"90","author":"N Knudsen","year":"2005","unstructured":"Knudsen N, Laurberg P, Rasmussen LB, B\u00fclow I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90(7):4019\u201324. https:\/\/doi.org\/10.1210\/jc.2004-2225.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01998-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:04:52Z","timestamp":1704971092000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01998-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1998"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01998-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Beijing Obstetrics and Gynecology Hospital, Capital Medical University Ethics Committee gave its approval to the study protocol on February 2nd, 2018 (reference number: 2018-KY-003-02). All participants provided their informed consent to be a part of this study and approved the sharing of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}